In the TCGA cohort, mutations in GNAQ/11, CYSLTR2, and PLCB4 (2.5%) were found in 92.5%, 4%, and 2.5% of the samples, respectively, highlighting the involvement of G-protein signaling in the biology of uveal melanoma. This evidence concerns the gene CYSLTR2 and uveal melanoma.